JOHN TRAN: Open Payments
NPI 1316444896 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$951 in 39 payments from 9 companies in 2025. Trend: 2023 $263 · 2024 $396 · 2025 $951
Food & beverage: $951
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 7 | $226 |
| ABBVIE INC. | 9 | $205 |
| Kowa Pharmaceuticals America, Inc. | 9 | $157 |
| Amgen Inc. | 3 | $126 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $117 |
| Lilly USA, LLC | 3 | $58 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Exact Sciences Corporation | 1 | $19 |
Products named: ZENPEP, ZORYVE, Kerendia, LINZESS, REPATHA, CREON, MOUNJARO, BEXSERO.
Industry payments across CA — which companies pay providers there.
